Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axis
Yuanyuan Zeng(Sichuan University), Zeyi Liu(Soochow University), Jian Zhao(Liaoning Cancer Hospital & Institute), Mengmeng Xu(Shanghai Jiao Tong University), Jianjie Zhu(Soochow University), Weijie Zhang(Soochow University), Jianjun Li(Soochow University), Anqi Wang(Soochow University), Yongkang Huang(Soochow University), Jian-An Huang(Soochow University), Zhengyan Wu(Kementerian Pendidikan Malaysia), Xiaohui Zhang(National Development and Reform Commission)
Cited by 6
Related Papers
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
|International Journal of Clinical Oncology|2017|315
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|314